Adverse vascular risk is related to cognitive decline in older adults
- PMID: 25471188
- PMCID: PMC4336578
- DOI: 10.3233/JAD-141812
Adverse vascular risk is related to cognitive decline in older adults
Abstract
Background: Cardiovascular disease (CVD) and related risk factors are associated with Alzheimer's disease (AD). This association is less well-defined in normal cognition (NC) or prodromal AD (mild cognitive impairment, MCI).
Objective: Cross-sectionally and longitudinally relate a vascular risk index to cognitive outcomes among elders free of clinical dementia.
Methods: 3,117 MCI (74 ± 8 years, 56% female) and 6,603 NC participants (72 ± 8 years, 68% female) were drawn from the National Alzheimer's Coordinating Center. A composite measure of vascular risk was defined using the Framingham Stroke Risk Profile (FSRP) score (i.e., age, systolic blood pressure, anti-hypertensive medication, diabetes, cigarette smoking, CVD history, atrial fibrillation). Ordinary linear regressions and generalized linear mixed models related baseline FSRP to cross-sectional and longitudinal cognitive outcomes, separately for NC and MCI, adjusting for age, gender, race, education, and follow-up time (in longitudinal models).
Results: In NC participants, increasing FSRP was related to worse baseline global cognition, information processing speed, and sequencing abilities (p-values <0.0001) and a worse longitudinal trajectory on all cognitive measures (p-values <0.0001). In MCI, increasing FSRP correlated with worse longitudinal delayed memory (p = 0.004). In secondary models using an age-excluded FSRP score, associations persisted in NC participants for global cognition, naming, information processing speed, and sequencing abilities.
Conclusions: An adverse vascular risk profile is associated with worse cognitive trajectory, especially global cognition, naming, and information processing speed, among NC elders. Future studies are needed to understand how effective management of CVD and related risk factors can modify cognitive decline to identify the ideal timeframe for primary prevention implementation.
Keywords: Blood pressure; Framingham Stroke Risk Profile; diabetes mellitus; smoking; stroke.
Figures
 
              
              
              
              
                
                
                References
- 
    - Kivipelto M, Laakso MP, Tuomilehto J, Nissinen A, Soininen H. Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: Potential for pharmacological intervention. CNS Drugs. 2002;16:435–444. - PubMed
 
- 
    - Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004;61:661–666. - PubMed
 
- 
    - Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, van Duijn CM, Breteler MM. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: The Rotterdam study. Lancet. 1998;351:1840–1843. - PubMed
 
Publication types
MeSH terms
Grants and funding
- T35 AG038027/AG/NIA NIH HHS/United States
- T32 MH065215/MH/NIMH NIH HHS/United States
- K23 AG048347/AG/NIA NIH HHS/United States
- U01 AG016976/AG/NIA NIH HHS/United States
- R01 HL111516/HL/NHLBI NIH HHS/United States
- U54 HD083211/HD/NICHD NIH HHS/United States
- R01-AG034962/AG/NIA NIH HHS/United States
- T32-MH65215/MH/NIMH NIH HHS/United States
- K23 AG030962/AG/NIA NIH HHS/United States
- K12 HD043483/HD/NICHD NIH HHS/United States
- L30 AG048601/AG/NIA NIH HHS/United States
- R01-HL11516/HL/NHLBI NIH HHS/United States
- T35-AG038027/AG/NIA NIH HHS/United States
- U01-AG016976/AG/NIA NIH HHS/United States
- K24-AG046373/AG/NIA NIH HHS/United States
- K24 AG046373/AG/NIA NIH HHS/United States
- R01 AG034962/AG/NIA NIH HHS/United States
- K23-AG030962/AG/NIA NIH HHS/United States
LinkOut - more resources
- Full Text Sources
 
        